Skip to main content
OpenTrials

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

233 public trials 71 recruiting studies
Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

NCT05602363

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • UC Irvine Health Orange, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

NCT05643742

Conditions
B-cell Lymphoma, B-cell Malignancy, Chronic Disease, +27 more
Locations
  • University of Kansas Westwood, Kansas, United States
  • Washington University St Louis, Missouri, United States
  • SCRI San Antonio, Texas, United States
  • University of Utah Salt Lake City, Utah, United States
View Trial Details
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

NCT05365659

Conditions
B-Cell Non-Hodgkin Lymphoma, B-cell Lymphoma, Diffuse Large B Cell Lymphoma, +15 more
Locations
  • University of Maryland Baltimore Baltimore, Maryland, United States
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Royal Hobart Hospital Hobart, Tasmania, Australia
View all 13 locations
View Trial Details
Recruiting

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

NCT05541341

Conditions
Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +16 more
Locations
  • Novartis Investigative Site Minas Gerais, Belo Horizonte, Brazil
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
  • Novartis Investigative Site Curitiba, Paraná, Brazil
  • Novartis Investigative Site São Paulo, Brazil
View Trial Details

Related conditions